aspirin has been researched along with Respiratory Tract Diseases in 95 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Changes in nasal and asthma symptoms, combined with changes in oral prednisone, were recorded daily during 4 weeks before and after desensitization." | 9.10 | Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. ( Berges-Gimeno, MP; Simon, RA; Stevenson, DD, 2003) |
| "Aspirin-Exacerbated Respiratory Disease (AERD) and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) are both characterized by the presence of chronic sinonasal inflammation and nasal polyps." | 8.93 | Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis. ( Schleimer, RP; Stevens, WW, 2016) |
| "The prevalence and mean provocative dose of oral aspirin (MPDA) triggering respiratory reactions in people with asthma have been inconsistently reported, and the relationship between NSAID-exacerbated respiratory disease (NERD) and asthma morbidity was less well quantified." | 8.91 | NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity. ( Donnan, PT; Guthrie, B; Jackson, C; Lipworth, BJ; Morales, DR; Santiago, VH, 2015) |
| "The presence of aspirin-exacerbated respiratory disease (AERD) in a patient with chronic rhinosinusitis with nasal polyps and asthma is associated with severe eosinophilic upper and lower airway disease." | 8.89 | Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. ( Mullol, J; Picado, C, 2013) |
| "Clinical features of aspirin-exacerbated respiratory disease (AERD) are characterized by overproduction of cysteinyl leukotrienes (LT) and eosinophil activation, in which epithelial cells contribute to eosinophilic airway inflammation." | 7.88 | Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease. ( Choi, Y; Kim, HM; Kim, SH; Park, HS; Pham, DL; Trinh, HKT, 2018) |
| "Data were compared between asthmatic patients who reported exacerbations after aspirin ingestion and those who did not." | 7.73 | Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. ( Borish, L; Hunt, J; Mascia, K; Patrie, J; Phillips, CD; Steinke, JW, 2005) |
| "By the first 6 months of aspirin treatment, there were significant reductions in sinus infections and numbers of short courses of prednisone and improvements in sense of smell and general assessment of nasal-sinus and asthma symptoms (P <." | 7.72 | Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. ( Berges-Gimeno, MP; Simon, RA; Stevenson, DD, 2003) |
| "Aspirin exacerbated respiratory disease (AERD) is comprised of aspirin/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis." | 5.20 | Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study. ( Au, M; Gupta, MK; Hoffbauer, S; Nayan, S; Sommer, DD; Sowerby, LJ, 2015) |
| "Twenty-one adult patients with asthma, chronic polypoid sinusitis, and a convincing history of acute respiratory reaction to the ingestion of aspirin or nonsteroidal anti-inflammatory drugs were selected." | 5.14 | The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. ( Alam, R; Katial, RK; Leung, R; Prasertsuntarasai, T; Strand, M; Zheng, W, 2010) |
| " Changes in nasal and asthma symptoms, combined with changes in oral prednisone, were recorded daily during 4 weeks before and after desensitization." | 5.10 | Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. ( Berges-Gimeno, MP; Simon, RA; Stevenson, DD, 2003) |
| "Aspirin-exacerbated respiratory disease is a chronic and treatment-resistant disease, characterized by the presence of eosinophilic rhinosinusitis, nasal polyposis, bronchial asthma, and nonsteroidal anti-inflammatory drugs hypersensitivity." | 4.98 | Aspirin exacerbated respiratory disease: Current topics and trends. ( Guaní-Guerra, E; Moreno-Paz, FJ; Rodríguez-Jiménez, JC; Terán, LM, 2018) |
| "Aspirin-Exacerbated Respiratory Disease (AERD) and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) are both characterized by the presence of chronic sinonasal inflammation and nasal polyps." | 4.93 | Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis. ( Schleimer, RP; Stevens, WW, 2016) |
| "The prevalence and mean provocative dose of oral aspirin (MPDA) triggering respiratory reactions in people with asthma have been inconsistently reported, and the relationship between NSAID-exacerbated respiratory disease (NERD) and asthma morbidity was less well quantified." | 4.91 | NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity. ( Donnan, PT; Guthrie, B; Jackson, C; Lipworth, BJ; Morales, DR; Santiago, VH, 2015) |
| "Nonsteroidal anti-inflammatory drugs (NSAIDs) cause bronchospasm in susceptible patients with asthma, often termed aspirin-exacerbated respiratory disease (AERD), with the risk being greatest after acute exposure." | 4.90 | Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials. ( Donnan, PT; Guthrie, B; Jackson, C; Lipworth, BJ; Morales, DR; Santiago, VH, 2014) |
| "The presence of aspirin-exacerbated respiratory disease (AERD) in a patient with chronic rhinosinusitis with nasal polyps and asthma is associated with severe eosinophilic upper and lower airway disease." | 4.89 | Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. ( Mullol, J; Picado, C, 2013) |
| "Aspirin-exacerbated respiratory disease (AERD) is an adult-onset condition that manifests as asthma, rhinosinusitis/nasal polyps, and sensitivity to aspirin and other cyclooxygenase-1 (COX-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)." | 4.82 | Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs. ( Simon, RA, 2004) |
| "Clinical features of aspirin-exacerbated respiratory disease (AERD) are characterized by overproduction of cysteinyl leukotrienes (LT) and eosinophil activation, in which epithelial cells contribute to eosinophilic airway inflammation." | 3.88 | Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease. ( Choi, Y; Kim, HM; Kim, SH; Park, HS; Pham, DL; Trinh, HKT, 2018) |
| "We sought to evaluate the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on T-cell activation of the IL-4 pathway in aspirin-sensitive patients with asthma and control subjects." | 3.83 | Nonsteroidal anti-inflammatory-induced inhibition of signal transducer and activator of transcription 6 (STAT-6) phosphorylation in aspirin-exacerbated respiratory disease. ( Alam, R; Burnett, T; Faino, A; Finkas, L; Katial, RK; Liu, S; Martucci, M, 2016) |
| "Aspirin-exacerbated respiratory disease (AERD) has been recognized in adults with chronic asthma." | 3.79 | Samter's triad in childhood: a warning for those prescribing NSAIDs. ( Ameratunga, R; Anderson, BJ; Dalziel, S; Randall, N, 2013) |
| " Often it is associated with non allergic rhinitis with eosinophilia syndrome (NARES), nasal polyposis and intolerance to Aspirin and NSAID's." | 3.74 | [Nonallergic diseases of the upper and lower airways]. ( Menz, G; Rothe, T, 2008) |
| "Data were compared between asthmatic patients who reported exacerbations after aspirin ingestion and those who did not." | 3.73 | Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. ( Borish, L; Hunt, J; Mascia, K; Patrie, J; Phillips, CD; Steinke, JW, 2005) |
| "The blocking effect of controller medications for asthma could have an effect on the outcome of aspirin challenges in patients suspected of having aspirin-exacerbated respiratory disease (AERD)." | 3.73 | The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. ( Simon, RA; Stevenson, DD; White, AA, 2005) |
| "By the first 6 months of aspirin treatment, there were significant reductions in sinus infections and numbers of short courses of prednisone and improvements in sense of smell and general assessment of nasal-sinus and asthma symptoms (P <." | 3.72 | Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. ( Berges-Gimeno, MP; Simon, RA; Stevenson, DD, 2003) |
| "Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinitis, nasal polyps, asthma, and precipitation of asthma and rhinitis attacks after ingestion of aspirin (ASA) and most nonsteroidal anti-inflammatory drugs (NSAIDs)." | 3.71 | The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. ( Berges-Gimeno, MP; Simon, RA; Stevenson, DD, 2002) |
| "Data collected from the Public Health Service Main Study of Reye's Syndrome and Medications were analyzed to assess the relationship between the development of Reye's syndrome and the dose of aspirin received during the antecedent respiratory or chickenpox illness." | 3.67 | Reye's syndrome and aspirin. Evidence for a dose-response effect. ( Gunn, WJ; Hurwitz, ES; Pinsky, PF; Schonberger, LB, 1988) |
| "We sought to determine the optimal daily dosage of aspirin treatment." | 2.73 | Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. ( Lee, JY; Simon, RA; Stevenson, DD, 2007) |
| "Prednisolone was therefore seen to be effective for treating variant angina that manifested as a non-respiratory tract symptom of aspirin-exacerbated respiratory disease." | 1.43 | [A CASE OF ASPIRIN-EXACERBATED RESPIRATORY DISEASE COMPLICATED BY REFRACTORY VARIANT ANGINA, WHICH SHOWED EXCELLENT RESPONSE TO STEROID TREATMENT]. ( Naito, T, 2016) |
| "Aspirin was associated with increased blood concentrations of 3MEIN-adduct for diets that did not contain supplemental vitamin E." | 1.31 | Effects of feeding aspirin and supplemental vitamin E on plasma concentrations of 3-methylindole, 3-methyleneindolenine-adduct concentrations in blood and pulmonary tissues, lung lesions, and growth performance in feedlot cattle. ( Bray, TM; Loneragan, GH; Mason, GL; Morley, PS; Thoren, MA; Wagner, JJ; Wittum, TE; Yost, GS, 2002) |
| "Fever was measured with a thermometer in 114 ill children, 103 of whom had at least one measured temperature of 37." | 1.27 | Antipyretic use among children during the 1983 influenza season. ( Brandenburg, N; Glezen, WP; Gustafson, TL; Johnson, CC; Taylor, JP, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (16.84) | 29.6817 |
| 2010's | 46 (48.42) | 24.3611 |
| 2020's | 14 (14.74) | 2.80 |
| Authors | Studies |
|---|---|
| Mullol, J | 3 |
| Boyce, J | 1 |
| Dahlén, SE | 1 |
| Dahlén, B | 1 |
| Picado, C | 3 |
| Bobolea, I | 1 |
| Cockcroft, DW | 1 |
| Cousins, K | 1 |
| Chen, CC | 1 |
| Sehanobish, E | 2 |
| Jerschow, E | 2 |
| Buchheit, KM | 2 |
| Hacker, J | 1 |
| Maurer, R | 1 |
| McGill, A | 1 |
| Ryan, T | 1 |
| Bensko, JC | 3 |
| Laidlaw, TM | 9 |
| Xiao, H | 1 |
| Meng, J | 1 |
| Chen, YS | 1 |
| Schlosser, RJ | 1 |
| He, SC | 1 |
| Xu, YT | 1 |
| Bosso, JV | 2 |
| Tripathi, SH | 1 |
| Kennedy, DW | 1 |
| Kohanski, MA | 2 |
| Cohen, NA | 2 |
| Palmer, JN | 1 |
| Adappa, ND | 1 |
| Hybar, H | 1 |
| Saki, N | 1 |
| Maleknia, M | 1 |
| Moghaddasi, M | 1 |
| Bordbar, A | 1 |
| Naghavi, M | 1 |
| Eraso, I | 1 |
| Sangiovanni, S | 1 |
| Morales, EI | 1 |
| Fernández-Trujillo, L | 1 |
| Staso, PJ | 1 |
| Wu, P | 1 |
| Cahill, KN | 4 |
| White, AA | 7 |
| Kuruvilla, M | 1 |
| Bensko, J | 1 |
| Levy, JM | 1 |
| Barrett, NA | 1 |
| Waldram, J | 1 |
| Walters, K | 1 |
| Simon, R | 1 |
| Woessner, K | 1 |
| Waalen, J | 1 |
| White, A | 3 |
| Lee, JH | 1 |
| Jung, CG | 1 |
| Park, HS | 2 |
| Rodríguez-Jiménez, JC | 1 |
| Moreno-Paz, FJ | 1 |
| Terán, LM | 1 |
| Guaní-Guerra, E | 1 |
| Trinh, HKT | 1 |
| Pham, DL | 1 |
| Choi, Y | 1 |
| Kim, HM | 1 |
| Kim, SH | 1 |
| Bochenek, G | 1 |
| Niżankowska-Mogilnicka, E | 1 |
| Stevenson, DD | 11 |
| Boyce, JA | 3 |
| Ameratunga, R | 1 |
| Randall, N | 1 |
| Dalziel, S | 1 |
| Anderson, BJ | 1 |
| Celikel, S | 1 |
| Stevenson, D | 2 |
| Erkorkmaz, U | 1 |
| Edward, JA | 1 |
| Sanyal, M | 1 |
| Ramakrishnan, VR | 1 |
| Le, W | 1 |
| Nguyen, AL | 1 |
| Kingdom, TT | 1 |
| Hwang, PH | 1 |
| Nayak, JV | 1 |
| Morales, DR | 2 |
| Lipworth, BJ | 2 |
| Guthrie, B | 2 |
| Jackson, C | 2 |
| Donnan, PT | 2 |
| Santiago, VH | 2 |
| Cutler, AJ | 1 |
| Kidder, MS | 1 |
| Liu, T | 1 |
| Cardet, JC | 1 |
| Chhay, H | 1 |
| Feng, C | 1 |
| Sánchez-Borges, M | 1 |
| Caballero-Fonseca, F | 1 |
| Capriles-Hulett, A | 1 |
| González-Aveledo, L | 1 |
| Sommer, DD | 1 |
| Hoffbauer, S | 1 |
| Au, M | 1 |
| Sowerby, LJ | 1 |
| Gupta, MK | 1 |
| Nayan, S | 1 |
| Esmaeilzadeh, H | 1 |
| Nabavi, M | 1 |
| Aryan, Z | 1 |
| Amirzargar, AA | 1 |
| Machado-Carvalho, L | 1 |
| Torres, R | 1 |
| Perez-Gonzalez, M | 1 |
| Alobid, I | 1 |
| Pujols, L | 1 |
| Roca-Ferrer, J | 1 |
| Katial, RK | 4 |
| Martucci, M | 1 |
| Burnett, T | 2 |
| Faino, A | 1 |
| Finkas, L | 1 |
| Liu, S | 1 |
| Alam, R | 2 |
| Naito, T | 1 |
| Makowska, JS | 2 |
| Olszewska-Ziąber, A | 1 |
| Bieńkiewicz, B | 1 |
| Lewandowska-Polak, A | 1 |
| Kurowski, M | 1 |
| Woźniakowski, B | 1 |
| Rotkiewicz, A | 1 |
| Kowalski, ML | 3 |
| Williams, AN | 1 |
| Stevens, WW | 1 |
| Schleimer, RP | 1 |
| Waldram, JD | 1 |
| Simon, RA | 9 |
| Wardzyńska, A | 1 |
| Hill, J | 1 |
| Katial, R | 1 |
| Steinke, JW | 2 |
| Payne, SC | 1 |
| Borish, L | 2 |
| Parker, AR | 1 |
| Ayars, AG | 1 |
| Altman, MC | 1 |
| Henderson, WR | 1 |
| Dahlin, A | 1 |
| Weiss, ST | 1 |
| Tajudeen, BA | 1 |
| Schwartz, JS | 1 |
| Rothe, T | 1 |
| Menz, G | 1 |
| González-Pérez, R | 1 |
| Poza-Guedes, P | 1 |
| Vives-Conesa, R | 1 |
| Tournoij, E | 1 |
| Peters, RJ | 1 |
| Langenberg, M | 1 |
| Kanhai, KJ | 1 |
| Moll, FL | 1 |
| Strand, M | 1 |
| Prasertsuntarasai, T | 1 |
| Leung, R | 1 |
| Zheng, W | 1 |
| Abayaratne, D | 1 |
| Kurukulaaratchy, RJ | 1 |
| Chang, J | 1 |
| Kim, TH | 1 |
| Lee, JY | 3 |
| Park, JS | 1 |
| Park, SW | 1 |
| Jang, AS | 2 |
| Byun, JY | 1 |
| Uh, ST | 2 |
| Koh, ES | 1 |
| Chung, IY | 1 |
| Park, CS | 2 |
| Kohyama, K | 1 |
| Hashimoto, M | 1 |
| Abe, S | 1 |
| Kodaira, K | 1 |
| Yukawa, T | 1 |
| Hozawa, S | 1 |
| Morioka, J | 1 |
| Inamura, H | 1 |
| Yano, M | 1 |
| Ota, M | 1 |
| Sagara, H | 1 |
| Kurosawa, M | 1 |
| Chang, JE | 1 |
| Ding, D | 1 |
| Martin-Lazaro, J | 1 |
| Hoyte, FC | 2 |
| Weber, RW | 1 |
| Negrete-Garcia, MC | 1 |
| Jiménez-Torres, CY | 1 |
| Alvarado-Vásquez, N | 1 |
| Montes-Vizuet, AR | 1 |
| Velázquez-Rodriguez, JR | 1 |
| Jimenez-Martinez, MC | 1 |
| Teran-Juárez, LM | 1 |
| Pasaje, CF | 1 |
| Bae, JS | 1 |
| Park, BL | 1 |
| Cheong, HS | 1 |
| Kim, MK | 1 |
| Kim, JH | 1 |
| Park, TJ | 1 |
| Lee, JS | 1 |
| Kim, Y | 1 |
| Shin, HD | 1 |
| Durrani, SR | 1 |
| Kelly, JT | 1 |
| Berges-Gimeno, MP | 3 |
| Loneragan, GH | 1 |
| Morley, PS | 1 |
| Wagner, JJ | 1 |
| Mason, GL | 1 |
| Yost, GS | 1 |
| Thoren, MA | 1 |
| Wittum, TE | 1 |
| Bray, TM | 1 |
| JONES, PN | 1 |
| BIGHAM, RS | 1 |
| MANNING, PR | 1 |
| McLANE, RA | 1 |
| HECK, CC | 1 |
| Yates, AB | 1 |
| deShazo, RD | 1 |
| Mascia, K | 1 |
| Patrie, J | 1 |
| Hunt, J | 1 |
| Phillips, CD | 1 |
| Bigby, T | 1 |
| Farooque, S | 1 |
| Lee, T | 1 |
| Hope, AP | 1 |
| Grilliat, JP | 1 |
| Moneret-Vautrin, DA | 1 |
| You, B | 1 |
| Reynier, A | 1 |
| Vizioli, A | 1 |
| Zamperini, D | 1 |
| Ursaia, G | 1 |
| Bartolucci, L | 1 |
| Canini, F | 1 |
| Fioroni, E | 1 |
| Pinchi, G | 1 |
| Carosi, M | 1 |
| Marchesani, F | 1 |
| Rizzo, S | 1 |
| Salvini, P | 1 |
| Mora, P | 1 |
| Levi, P | 1 |
| Marostica, G | 1 |
| Saldi, M | 1 |
| Monson, RR | 1 |
| Hall, AP | 1 |
| Hurwitz, ES | 2 |
| Riggs, BS | 1 |
| Kulig, K | 1 |
| Rumack, BH | 1 |
| Spaulding, GL | 1 |
| Pinsky, PF | 1 |
| Schonberger, LB | 1 |
| Gunn, WJ | 1 |
| Dryburgh, DR | 1 |
| Taylor, JP | 1 |
| Gustafson, TL | 1 |
| Johnson, CC | 1 |
| Brandenburg, N | 1 |
| Glezen, WP | 1 |
| Nakano, J | 1 |
| Koss, MC | 1 |
| Vojtìsek, O | 1 |
| Kankovà, D | 1 |
| Mikhaĭlova, IN | 1 |
| Monakhova, MA | 1 |
| Tarasenkova, TA | 1 |
| Nikol'skaia, NV | 1 |
| Ponomarev, VS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of PDG2 in the Aspirin-Induced Reactions and in the Treatment of Aspirin-Exacerbated Respiratory Disease[NCT02824523] | 40 participants (Actual) | Observational | 2016-07-31 | Completed | |||
| Dupilumab as add-on Therapy for Aspirin-exacerbated Respiratory Disease (AERD)[NCT03595488] | Phase 2 | 11 participants (Actual) | Interventional | 2018-09-05 | Completed | ||
| The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases[NCT01867281] | Phase 4 | 32 participants (Actual) | Interventional | 2013-06-30 | Completed | ||
| Double Blind Study to Determine Effect of Omalizumab Treatment in Patients With the Co-Morbid Conditions of Aspirin Exacerbated Respiratory Disease(AERD) and Allergic Asthma and Rhinitis.[NCT00286416] | 60 participants | Interventional | 2006-01-31 | Recruiting | |||
| Challenge Test for Acetylsalicylic Acid Hypersensitivity[NCT01681615] | 50 participants (Anticipated) | Interventional | 2012-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
30 reviews available for aspirin and Respiratory Tract Diseases
| Article | Year |
|---|---|
Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches.
Topics: Animals; Aspirin; Disease Progression; Genetic Predisposition to Disease; Humans; Polymorphism, Gene | 2021 |
Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: A systematic review of the literature and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Humans; Respiratory Tract Diseases | 2021 |
An update on the management of aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Disease Management; | 2018 |
Aspirin exacerbated respiratory disease: Current topics and trends.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Arachidonic Acid; Aspirin; A | 2018 |
Clinical updates in aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Disease Management; Healt | 2019 |
Aspirin-exacerbated respiratory disease: clinical disease and diagnosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Hypersensitivity; Humans; Prevalence; Respira | 2013 |
Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Hypersensitivity; Humans; Nasal Polyps; Respi | 2013 |
Aspirin desensitization in aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Drug Hypersensitivit | 2013 |
Pathogenesis of aspirin-exacerbated respiratory disease and reactions.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Hypersensitivity; Humans; Inflammati | 2013 |
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Spasm; Celecoxib; Clinical Trial | 2014 |
NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Provocation Tests; Disease Progr | 2015 |
Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease.
Topics: Alcohols; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Comorbidity; Cross Reactions; C | 2016 |
Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchial Provocation Tests; Humans; Nasal Provoca | 2016 |
Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Cytokines; Humans; Immunity, Innate; I | 2016 |
Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chronic Disease; Humans; Respiratory Tract Disease | 2016 |
Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Diagnostic Technique | 2016 |
Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Desensitization, Immunol | 2016 |
Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Desensitization, Immunologic; Humans; L | 2016 |
Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Cytokines; Eosinophils; Gene Expressio | 2016 |
Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Aspirin; Humans; Inflammation | 2016 |
Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.
Topics: Alleles; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Disease Management; Eosinophi | 2016 |
The role of aspirin desensitization in the management of aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Disease Management; | 2017 |
Allergic and nonallergic drug reactions.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cephalosporins; Chemical an | 2003 |
Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Cyclooxygenase Inhibitors; Desensit | 2004 |
Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Humans; Nasal Polyps; R | 2000 |
Current status of aspirin and acetaminophen intoxication.
Topics: Acetaminophen; Aspirin; Chemical and Drug Induced Liver Injury; Gastrointestinal Diseases; Humans; R | 1987 |
The use of aminophylline and aspirin in small animal practice: effective therapy or dangerous placebos?
Topics: Aminophylline; Animals; Aspirin; Cardiovascular Diseases; Cat Diseases; Cats; Dog Diseases; Dogs; Re | 1986 |
Vitamin C and chiropractic.
Topics: Age Factors; Alcoholism; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ascorbic Acid; As | 1985 |
Pathophysiologic roles of prostaglandins and the action of aspirin-like drugs.
Topics: Analgesics; Animals; Aspirin; Cardiovascular System; Cats; Central Nervous System; Diarrhea; Digesti | 1973 |
[Polymyalgia rheumatica (comprehensive review)].
Topics: Age Factors; Aspirin; Blood Protein Electrophoresis; Blood Sedimentation; Diagnosis, Differential; G | 1973 |
11 trials available for aspirin and Respiratory Tract Diseases
| Article | Year |
|---|---|
Use of nasal inspiratory flow rates in the measurement of aspirin-induced respiratory reactions.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Inhalation; Ketorolac; Male | 2013 |
Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study.
Topics: Adult; Aged; Aspirin; Asthma; Cross-Over Studies; Desensitization, Immunologic; Drug Hypersensitivit | 2015 |
Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases; HLA-DQB302.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Double-Blind | 2015 |
The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Biomarkers; Chronic Disease; | 2010 |
Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Adult; Aged; Aspirin; Asthma; Female; Glucocorticoids; Humans; Male; Middle Aged; Prednisone; Respir | 2003 |
Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease.
Topics: Administration, Intranasal; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Dr | 2006 |
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Humans; Respiratory | 2007 |
[Clinical trial of guacetisal in aged subjects with inflammatory diseases of the respiratory tract].
Topics: Aged; Anti-Inflammatory Agents; Aspirin; Bronchitis; Clinical Trials as Topic; Common Cold; Female; | 1982 |
[Clinical evaluation of the therapeutic effectiveness of a new drug with anti-inflammatory-balsamic action, guacetisal, in respiratory tract diseases].
Topics: Adolescent; Adult; Aged; Aspirin; Bronchitis; Bronchopneumonia; Chronic Disease; Clinical Trials as | 1981 |
[Guacetisal: a new molecule with balsamic-antiphlogistic action. Clinical study].
Topics: Adult; Aged; Aspirin; Asthma; Bronchitis; Bronchopneumonia; Clinical Trials as Topic; Female; Humans | 1981 |
[Broncaspin in respiratory diseases in pediatrics. Clinical contribution].
Topics: Aspirin; Bronchitis; Bronchopneumonia; Child; Child, Preschool; Clinical Trials as Topic; Cough; Dys | 1981 |
54 other studies available for aspirin and Respiratory Tract Diseases
| Article | Year |
|---|---|
Eicosanoid dysregulation and type 2 inflammation in AERD.
Topics: Aspirin; Biomarkers; Disease Susceptibility; Eicosanoids; Humans; Inflammation; Respiratory Tract Di | 2021 |
NSAID-exacerbated respiratory disease, dupilumab and aspirin tolerance.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Aspirin; Humans; Respira | 2023 |
The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Eicosanoids; Humans; Leukotrienes; Oxylipin | 2023 |
Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Aspirin; Asthma, Aspirin | 2023 |
[Aspirin challenge tests in non-steroidal anti-inflammatory drugs-exacerbated respiratory disease: clinical application and current research].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Respiration Disorders; Respiratory Tract D | 2023 |
A retrospective analysis of bronchiectasis in patients with aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Bronchiectasis; Humans; R | 2020 |
Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Desensitization, Immunolo | 2020 |
[Aspirin-exacerbated respiratory disease: current diagnosis and treatment].
Topics: Aspirin; Asthma, Aspirin-Induced; Desensitization, Immunologic; Humans; Respiratory Tract Diseases; | 2020 |
Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Humans; Respiratory Tract | 2021 |
Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease.
Topics: Administration, Intranasal; Adult; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, D | 2021 |
COVID-19 in a series of patients with aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; COVID-19; Humans; Respira | 2021 |
Epithelial dysregulation in chronic rhinosinusitis with nasal polyposis (CRSwNP) and aspirin-exacerbated respiratory disease (AERD).
Topics: Aspirin; Biomarkers; Chronic Disease; Disease Progression; Disease Susceptibility; Humans; Nasal Pol | 2021 |
Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Desens | 2018 |
Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease.
Topics: Adult; Aspirin; Asthma, Aspirin-Induced; Biomarkers; Cell Line; Computational Biology; Cytokines; Eo | 2018 |
Samter's triad in childhood: a warning for those prescribing NSAIDs.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthm | 2013 |
Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients.
Topics: Adult; Aged; Aspirin; Chronic Disease; Ethmoid Sinus; Female; Flow Cytometry; Glucocorticoids; Granu | 2013 |
Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoproston | 2014 |
Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.
Topics: Adult; Aspirin; Basophils; Desensitization, Immunologic; Drug Hypersensitivity; Eicosanoids; Eosinop | 2015 |
Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Asp | 2015 |
Altered expression and signalling of EP2 receptor in nasal polyps of AERD patients: role in inflammation and remodelling.
Topics: Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Proliferation; Cyclic AMP; Dinop | 2016 |
Nonsteroidal anti-inflammatory-induced inhibition of signal transducer and activator of transcription 6 (STAT-6) phosphorylation in aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Case-Control Studies; Cytokines; Drug Hype | 2016 |
[A CASE OF ASPIRIN-EXACERBATED RESPIRATORY DISEASE COMPLICATED BY REFRACTORY VARIANT ANGINA, WHICH SHOWED EXCELLENT RESPONSE TO STEROID TREATMENT].
Topics: Angina Pectoris, Variant; Aspirin; Drug Hypersensitivity; Female; Humans; Middle Aged; Prednisolone; | 2016 |
Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Creatine; Desensitization, Immunolo | 2016 |
[Nonallergic diseases of the upper and lower airways].
Topics: Aspirin; Asthma; Bronchitis; Diagnosis, Differential; Drug Hypersensitivity; Eosinophilia; Humans; I | 2008 |
Systemic and local responses in aspirin-exacerbated respiratory disease: same or different disease?
Topics: Aspirin; Bronchial Provocation Tests; Drug Hypersensitivity; Humans; Respiratory Tract Diseases | 2008 |
The prevalence of intolerance for low-dose acetylsalicylacid in the secondary prevention of atherothrombosis.
Topics: Administration, Oral; Aged; Angioedema; Aspirin; Dose-Response Relationship, Drug; Embolism, Cholest | 2009 |
Recognising the risk of aspirin-sensitive respiratory disease in a patient with asthma who has previously tolerated aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Drug Hypersensitivity; Drug Tolerance; Hum | 2011 |
Aspirin-exacerbated respiratory disease: is it in our DNA?
Topics: Aspirin; Drug Hypersensitivity; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucl | 2011 |
Fatty acid binding protein 1 is related with development of aspirin-exacerbated respiratory disease.
Topics: Aspirin; Blotting, Western; Chromatography, Liquid; Electrophoresis, Polyacrylamide Gel; Fatty Acid- | 2011 |
Thromboxane A2 receptor +795T>C and chemoattractant receptor-homologous molecule expressed on Th2 cells -466T>C gene polymorphisms in patients with aspirin-exacerbated respiratory disease.
Topics: Adult; Aged; Alleles; Aspirin; Female; Gene Frequency; Genotype; Humans; Logistic Models; Male; Midd | 2012 |
Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease.
Topics: Adolescent; Adult; Aged; Aspirin; Asthma, Aspirin-Induced; Case-Control Studies; Environmental Expos | 2012 |
Pancreatitis as a novel complication of aspirin therapy in patients with aspirin-exacerbated respiratory disease.
Topics: Aged; Aspirin; Female; Humans; Male; Middle Aged; Pancreatitis; Respiratory Tract Diseases | 2012 |
Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease.
Topics: Aspirin; Female; Humans; Male; Pancreatitis; Respiratory Tract Diseases | 2012 |
Galectin-10 is released in the nasal lavage fluid of patients with aspirin-sensitive respiratory disease.
Topics: Adolescent; Adult; Aged; Aspirin; Enzyme-Linked Immunosorbent Assay; Female; Galectins; Humans; Male | 2012 |
A possible association between ZNRD1 and aspirin-induced airway bronchoconstriction in a Korean population.
Topics: Adolescent; Adult; Aged; Asian People; Aspirin; Asthma; Bronchoconstriction; Cohort Studies; DNA-Bin | 2012 |
Pancreatitis as a complication of aspirin desensitization for aspirin-exacerbated respiratory disease.
Topics: Aspirin; Female; Humans; Male; Pancreatitis; Respiratory Tract Diseases | 2013 |
Reply: To PMID 22236727.
Topics: Aspirin; Female; Humans; Male; Pancreatitis; Respiratory Tract Diseases | 2013 |
The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Provocatio | 2002 |
Effects of feeding aspirin and supplemental vitamin E on plasma concentrations of 3-methylindole, 3-methyleneindolenine-adduct concentrations in blood and pulmonary tissues, lung lesions, and growth performance in feedlot cattle.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Weight; Cattle; Cattle Diseases; Die | 2002 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Inhalation; Administration, Intranasal; Adrenal Cortex Hormones; Aspirin; Asthma; Br | 2003 |
Use of antibiotics in nonbacterial respiratory infections.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Aspirin; Dermatologic Agents; Erythromycin; Huma | 1953 |
Combined drug therapy in acute upper respiratory infections.
Topics: Anti-Allergic Agents; Aspirin; Caffeine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans | 1954 |
Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease.
Topics: Adult; Aspirin; Asthma; Case-Control Studies; Chronic Disease; Cohort Studies; Drug Hypersensitivity | 2005 |
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Anti-Inflammatory Agents, N | 2005 |
Mechanisms of aspirin-sensitive respiratory disease--a two-compartment model.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Aspirin; Asthma; Cyclooxygenas | 2007 |
Failure to maintain an aspirin-desensitized state in a patient with aspirin-exacerbated respiratory disease.
Topics: Administration, Oral; Adult; Aspirin; Desensitization, Immunologic; Drug Hypersensitivity; Humans; M | 2006 |
[Respiratory manifestations and intolerance to aspirin and non-steroidal anti-inflammatory agents].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Aspirin; Bra | 1984 |
[Clinical experiences with guacetisal].
Topics: Aspirin; Bronchitis; Humans; Lung Diseases, Obstructive; Respiratory Tract Diseases | 1981 |
[Broncaspin in the therapy of pediatric diseases of the respiratory tract].
Topics: Age Factors; Anti-Bacterial Agents; Aspirin; Bronchitis; Bronchopneumonia; Child; Child, Preschool; | 1981 |
Mortality among arthritics.
Topics: Aged; Arthritis, Rheumatoid; Aspirin; Cardiovascular Diseases; Central Nervous System Diseases; Coro | 1976 |
The changing epidemiology of Reye's syndrome in the United States: further evidence for a public health success.
Topics: Adolescent; Aspirin; Chickenpox; Child; Child, Preschool; Diagnosis, Differential; Humans; Infant; L | 1988 |
Reye's syndrome and aspirin. Evidence for a dose-response effect.
Topics: Adolescent; Aspirin; Chickenpox; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; | 1988 |
Antipyretic use among children during the 1983 influenza season.
Topics: Acetaminophen; Adolescent; Adult; Aspirin; Chickenpox; Child; Child, Preschool; Female; Fever; Healt | 1985 |
[Primary results of continuous (annual) bicillin-aspirin prophylaxis of rheumatism recurrences in adults].
Topics: Adolescent; Adult; Aged; Aspirin; Female; Humans; Influenza, Human; Male; Middle Aged; Penicillin G | 1970 |